ID: ALA5082760

Max Phase: Preclinical

Molecular Formula: C8H11NOS

Molecular Weight: 169.25

Molecule Type: Unknown

Associated Items:

Representations

Canonical SMILES:  NC[C@@H]1OCCc2ccsc21

Standard InChI:  InChI=1S/C8H11NOS/c9-5-7-8-6(1-3-10-7)2-4-11-8/h2,4,7H,1,3,5,9H2/t7-/m0/s1

Standard InChI Key:  RUVLCKYDYIYWBH-ZETCQYMHSA-N

Associated Targets(Human)

Trace amine-associated receptor 1 1397 Activities

Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID

Molecule Features

Natural Product: NoOral: NoChemical Probe: NoParenteral: No
Molecule Type: UnknownTopical: NoFirst In Class: NoBlack Box: No
Chirality: NoAvailability: NoProdrug: No

Drug Indications

MESH IDMESH Heading EFO IDsEFO TermsMax Phase for IndicationReferences

Mechanisms of Action

Mechanism of ActionAction Typetarget IDTarget NameTarget TypeTarget OrganismBinding Site NameReferences

Properties

Molecular Weight: 169.25Molecular Weight (Monoisotopic): 169.0561AlogP: 1.32#Rotatable Bonds: 1
Polar Surface Area: 35.25Molecular Species: BASEHBA: 3HBD: 1
#RO5 Violations: 0HBA (Lipinski): 2HBD (Lipinski): 2#RO5 Violations (Lipinski): 0
CX Acidic pKa: CX Basic pKa: 8.86CX LogP: 1.06CX LogD: -0.40
Aromatic Rings: 1Heavy Atoms: 11QED Weighted: 0.69Np Likeness Score: -0.88

References

1. Heffernan MLR, Herman LW, Brown S, Jones PG, Shao L, Hewitt MC, Campbell JE, Dedic N, Hopkins SC, Koblan KS, Xie L..  (2022)  Ulotaront: A TAAR1 Agonist for the Treatment of Schizophrenia.,  13  (1.0): [PMID:35047111] [10.1021/acsmedchemlett.1c00527]

Source